Back to Search Start Over

MRI-based radiomic feature analysis of end-stage liver disease for severity stratification

Authors :
Nitsch, Jennifer
Sack, Jordan
Halle, Michael W.
Moltz, Jan H.
Wall, April
Rutherford, Anna E.
Kikinis, Ron
Meine, Hans
Source :
International Journal of Computer Assisted Radiology and Surgery; March 2021, Vol. 16 Issue: 3 p457-466, 10p
Publication Year :
2021

Abstract

Purpose: We aimed to develop a predictive model of disease severity for cirrhosis using MRI-derived radiomic features of the liver and spleen and compared it to the existing disease severity metrics of MELD score and clinical decompensation. The MELD score is compiled solely by blood parameters, and so far, it was not investigated if extracted image-based features have the potential to reflect severity to potentially complement the calculated score. Methods: This was a retrospective study of eligible patients with cirrhosis (<inline-formula id="IEq1"><alternatives><math><mrow><mi>n</mi><mo>=</mo><mn>90</mn></mrow></math><tex-math id="IEq1_TeX">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$n=90$$\end{document}</tex-math><inline-graphic href="11548_2020_2295_Article_IEq1.gif"></inline-graphic></alternatives></inline-formula>) who underwent a contrast-enhanced MR screening protocol for hepatocellular carcinoma (HCC) screening at a tertiary academic center from 2015 to 2018. Radiomic feature analyses were used to train four prediction models for assessing the patient’s condition at time of scan: MELD score, MELD score <inline-formula id="IEq2"><alternatives><math><mo>≥</mo></math><tex-math id="IEq2_TeX">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\ge $$\end{document}</tex-math><inline-graphic href="11548_2020_2295_Article_IEq2.gif"></inline-graphic></alternatives></inline-formula>9 (median score of the cohort), MELD score <inline-formula id="IEq3"><alternatives><math><mo>≥</mo></math><tex-math id="IEq3_TeX">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\ge $$\end{document}</tex-math><inline-graphic href="11548_2020_2295_Article_IEq3.gif"></inline-graphic></alternatives></inline-formula>15 (the inflection between the risk and benefit of transplant), and clinical decompensation. Liver and spleen segmentations were used for feature extraction, followed by cross-validated random forest classification. Results: Radiomic features of the liver and spleen were most predictive of clinical decompensation (AUC 0.84), which the MELD score could predict with an AUC of 0.78. Using liver or spleen features alone had slightly lower discrimination ability (AUC of 0.82 for liver and AUC of 0.78 for spleen features only), although this was not statistically significant on our cohort. When radiomic prediction models were trained to predict continuous MELD scores, there was poor correlation. When stratifying risk by splitting our cohort at the median MELD 9 or at MELD 15, our models achieved AUCs of 0.78 or 0.66, respectively. Conclusions: We demonstrated that MRI-based radiomic features of the liver and spleen have the potential to predict the severity of liver cirrhosis, using decompensation or MELD status as imperfect surrogate measures for disease severity.

Details

Language :
English
ISSN :
18616410 and 18616429
Volume :
16
Issue :
3
Database :
Supplemental Index
Journal :
International Journal of Computer Assisted Radiology and Surgery
Publication Type :
Periodical
Accession number :
ejs55461334
Full Text :
https://doi.org/10.1007/s11548-020-02295-9